Objectives: There is currently limited local and international literature on the characteristics of uro-oncology multi-disciplinary team meetings (MDTMs) and their impact on clinical decision making. The aims of this study were to provide a comprehensive descriptive analysis of MDTMs at an Australian tertiary hospital over a 12-month period and their impacts on patient management, and to evaluate adherence to MDTM plans. Methods: We conducted a review of a prospectively maintained database of all uro-oncology MDTMs held within the Northern Adelaide Local Health Network (NALHN) over a 12-month period in 2020–2021. Results: During this 12-month period, 24 MDT meetings were conducted, in which 280 patients were discussed. Overall, MDTMs resulted in modifications to the management of 25.7% of patients, which was consistent across all three major tumour streams (24% for prostate cancer, 29% for renal cell carcinoma, and 22% for urothelial carcinoma). MDTMs also facilitated cross referrals between specialties for 105 patients (37.5%), including 5 patients who were considered for entry into clinical trials. There was a high acceptance rate, with adherence to MDT recommendations for 270 of the 278 patients discussed (96.4%). MDTM plans were fully implemented within a 6-month period. Conclusions: We provided a detailed analysis of uro-oncology MDTMs at an Australian tertiary referral centre, demonstrating that MDTMs facilitate optimal cancer management for patients with urological cancers.
No takes yet. Share an insight, caveat, or question.
Shanmugasundaram et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: